297 related articles for article (PubMed ID: 16268664)
21. The pediatric psychopharmacology of autism spectrum disorder: A systematic review - Part I: The past and the present.
Persico AM; Ricciardello A; Lamberti M; Turriziani L; Cucinotta F; Brogna C; Vitiello B; Arango C
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Aug; 110():110326. PubMed ID: 33857522
[TBL] [Abstract][Full Text] [Related]
22. Atypical antipsychotics in children and adolescents with autistic and other pervasive developmental disorders.
McDougle CJ; Stigler KA; Erickson CA; Posey DJ
J Clin Psychiatry; 2008; 69 Suppl 4():15-20. PubMed ID: 18533764
[TBL] [Abstract][Full Text] [Related]
23. Pharmacotherapy to control behavioral symptoms in children with autism.
Doyle CA; McDougle CJ
Expert Opin Pharmacother; 2012 Aug; 13(11):1615-29. PubMed ID: 22550944
[TBL] [Abstract][Full Text] [Related]
24. Management of hyperactivity and other acting-out problems in patients with autism spectrum disorder.
Aman MG
Semin Pediatr Neurol; 2004 Sep; 11(3):225-8. PubMed ID: 15575418
[TBL] [Abstract][Full Text] [Related]
25. Targeted treatments for symptom domains in child and adolescent autism.
Hollander E; Phillips AT; Yeh CC
Lancet; 2003 Aug; 362(9385):732-4. PubMed ID: 12957098
[TBL] [Abstract][Full Text] [Related]
26. Pharmacotherapy of pervasive developmental disorders in children and adolescents.
Masi G
CNS Drugs; 2004; 18(14):1031-52. PubMed ID: 15584771
[TBL] [Abstract][Full Text] [Related]
27. Aripiprazole for autism spectrum disorders (ASD).
Ching H; Pringsheim T
Cochrane Database Syst Rev; 2012 May; (5):CD009043. PubMed ID: 22592735
[TBL] [Abstract][Full Text] [Related]
28. The use of selective serotonin reuptake inhibitors in autism and related disorders.
Posey DJ; Erickson CA; Stigler KA; McDougle CJ
J Child Adolesc Psychopharmacol; 2006; 16(1-2):181-6. PubMed ID: 16553538
[TBL] [Abstract][Full Text] [Related]
29. Developing drugs for core social and communication impairment in autism.
Posey DJ; Erickson CA; McDougle CJ
Child Adolesc Psychiatr Clin N Am; 2008 Oct; 17(4):787-801, viii-ix. PubMed ID: 18775370
[TBL] [Abstract][Full Text] [Related]
30. Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD).
Williams K; Brignell A; Randall M; Silove N; Hazell P
Cochrane Database Syst Rev; 2013 Aug; (8):CD004677. PubMed ID: 23959778
[TBL] [Abstract][Full Text] [Related]
31. Second generation antipsychotics in Asperger's Disorder and high functioning autism: a systematic review of the literature and effectiveness of meta-analysis.
Sochocky N; Milin R
Curr Clin Pharmacol; 2013 Nov; 8(4):370-9. PubMed ID: 24050741
[TBL] [Abstract][Full Text] [Related]
32. Parent-rated anxiety symptoms in children with pervasive developmental disorders: frequency and association with core autism symptoms and cognitive functioning.
Sukhodolsky DG; Scahill L; Gadow KD; Arnold LE; Aman MG; McDougle CJ; McCracken JT; Tierney E; Williams White S; Lecavalier L; Vitiello B
J Abnorm Child Psychol; 2008 Jan; 36(1):117-28. PubMed ID: 17674186
[TBL] [Abstract][Full Text] [Related]
33. Medications for adolescents and young adults with autism spectrum disorders: a systematic review.
Dove D; Warren Z; McPheeters ML; Taylor JL; Sathe NA; Veenstra-VanderWeele J
Pediatrics; 2012 Oct; 130(4):717-26. PubMed ID: 23008452
[TBL] [Abstract][Full Text] [Related]
34. An open trial of divalproex sodium in autism spectrum disorders.
Hollander E; Dolgoff-Kaspar R; Cartwright C; Rawitt R; Novotny S
J Clin Psychiatry; 2001 Jul; 62(7):530-4. PubMed ID: 11488363
[TBL] [Abstract][Full Text] [Related]
35. Systematic review of randomized controlled trials of atypical antipsychotics and selective serotonin reuptake inhibitors for behavioural problems associated with pervasive developmental disorders.
Dinca O; Paul M; Spencer NJ
J Psychopharmacol; 2005 Sep; 19(5):521-32. PubMed ID: 16166190
[TBL] [Abstract][Full Text] [Related]
36. Atypical antipsychotics in the treatment of children and adolescents with pervasive developmental disorders.
Politte LC; McDougle CJ
Psychopharmacology (Berl); 2014 Mar; 231(6):1023-36. PubMed ID: 23552907
[TBL] [Abstract][Full Text] [Related]
37. Selective serotonin reuptake inhibitors in autism: a review of efficacy and tolerability.
Kolevzon A; Mathewson KA; Hollander E
J Clin Psychiatry; 2006 Mar; 67(3):407-14. PubMed ID: 16649827
[TBL] [Abstract][Full Text] [Related]
38. Children and autism--Part 1--recognition and pharmacological management.
Angley M; Young R; Ellis D; Chan W; McKinnon R
Aust Fam Physician; 2007 Sep; 36(9):741-4. PubMed ID: 17915375
[TBL] [Abstract][Full Text] [Related]
39. An update on pharmacotherapy for autism spectrum disorder in children and adolescents.
Ji N; Findling RL
Curr Opin Psychiatry; 2015 Mar; 28(2):91-101. PubMed ID: 25602248
[TBL] [Abstract][Full Text] [Related]
40. Psychopharmacology of autism spectrum disorders: a selective review.
Mohiuddin S; Ghaziuddin M
Autism; 2013 Nov; 17(6):645-54. PubMed ID: 22892891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
